Tag: genomics
-
Company Helps Labs Build Gene, Cell Therapy Businesses
A new company formed offering full-scale facilities to develop cell and gene therapy products spun-off from academic research labs.
-
Wearables, Genetics Reveal Early Health Issues
Genetic and personal health data, including from wearable devices, from more than 100 healthy volunteers for several years revealed many early signs of disease.
-
Start-Up to Use Crispr for Heart Disease, Gains $59M
A new biotechnology enterprise plans to apply genetic analysis and the gene-editing technology Crispr to reduce the risk of coronary artery disease.
-
Kidney Diagnostics Receive FDA Breakthrough Tag
An algorithm-driven diagnostic test for chronic kidney disease is receiving a breakthrough device designation from the Food and Drug Administration.
-
DNA Nanoscale Capsules Designed for Drug Delivery
Researchers in Finland developed tiny drug-delivery capsules made of folded pieces of DNA, with the capsules opening and closing in specified chemical environments.
-
A.I. Speeds Infant Genetic Disease Diagnostics
Hospital, academic, and industry researchers devised automated techniques including artificial intelligence to sharply reduce the time for diagnosing genetic diseases in infants.
-
Crispr Made More Immune-System Safe
Researchers at Arizona State University created a process to make the genome editing technique Crispr less likely to cause an immune system reaction in patients.
-
Precision Medicine Tested for Combination Cancer Therapies
Results from a clinical trial show precision medicine, where the genomic nature of tumors guides the choice of treatment, can identify a combination of cancer therapies with better outcomes for patients.
-
Engineered Moth to Control Soybean Pest
A company providing genetically engineered insects to control threats to health and agriculture is designing a modified moth that now destroys soybeans and other crops.
-
Biotechs Partner on Gene Silencing in $1.1B Deal
Two biotechnology companies plan to develop new therapies mainly for eye and neurological diseases that silence genes responsible for those conditions.